The role of dyslipidemia and statins in venous thromboembolism
Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the...
Na minha lista:
| Publicado no: | Curr Control Trials Cardiovasc Med |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2001
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59643/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806791/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-4-165 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
